Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Peptide therapeutics: targeting the undruggable space
Clinical research with Afamelanotide
Peptides sit in a unique space between small molecules and large biologics, often requiring a hybrid approach to production
First, because 4MP causes considerable phospho-JNK inhibition which negatively impacts p53 activation and necrosis 92 , we considered that 4MP causes a conservative 80% decrease of p53 activation and simulated this by multiplying the phosphorylation rate of p53 with parameter k 4MP JNK = 0.2 (i.e., decreasing the phosphorylation rate)
[9] A modified version of CJC-1295 has also been evaluated for its actions on diverse physiological functions
US$ 20.21
US$ 19.99
US$ 21.79
US$ 29.18
US$ 21.57
